ISCV
iShares Morningstar Small Cap Value ETF
SMB
HML
Adj. R2
0.970
Rel. Sharpe
0.861
Mkt beta
1.01
AUM
US$631M
MER
0.06%
Valuation
124
ETF comparison
Verified factor-similar pair
ISCV vs IVOV
These two ETFs meet the same FF6 US comparison criteria: US-listed equity ETFs, the same USD model basis, at least one material non-market factor, and 100% overlap in statistically significant material factor exposure.
SMB
HML
Similarity score
91
Near substitute
The score combines exposure-level distance, factor-vector shape, market-beta closeness, and a small backtested relative-Sharpe term.
Quick Read
- IVOV has the higher backtested relative Sharpe (0.934 vs 0.861).
- ISCV has the lower published fee (0.06% vs 0.10%).
- IVOV is cheaper on dividend valuation (114 vs 124, where 100 is each fund's historical median).
- ISCV has the stronger regression fit (adjusted R-squared 0.970 vs 0.954).
These are screening signals, not a complete review of portfolio construction, turnover, taxes, or trading quality.
IVOV
Vanguard S&P Mid-Cap 400 Value ETF
SMB
HML
Adj. R2
0.954
Rel. Sharpe
0.934
Mkt beta
1.00
AUM
US$1.2B
MER
0.10%
Valuation
114
Factor Exposure Match
Blue bars compare raw factor beta magnitude. Green bars compare absolute t-stat strength. Dim bars indicate the t-stat is below 1.96.
SMB
diff +0.17
HML
diff +0.05
RMW
diff -0.05
CMA
diff +0.05
UMD
diff -0.03
Why This Pair Matches
Exposure level
89
Exposure shape
99
Mkt beta diff
0.01
Rel. Sharpe diff
0.072
This comparison focuses on measured factor exposure. It does not compare holdings methodology, turnover, tax handling, or issuer process. Backtested relative Sharpe is a secondary signal rather than a stand-alone forecast. See methodology.
Monthly updates
Get the next US ETF leaders update
Get one monthly email when the US leaders table refreshes, plus methodology and comparison-page updates.
Monthly leaders refresh
Download-access updates
Low-volume research notes
One monthly email when the data drop lands. This browser will remember you after signup.